https://adisinsight.springer.com/drugsafety/803923400?error=cookies_not_supported&code=55e09788-c059-4910-9566-af8abb195a65
Eltrombopag/Romiplostim - AdisInsight
Ninety-one adult patients with relapsed or refractory immune thrombocytopenia received eltrombopag or romiplostim and were evaluated for lack of efficacy,
eltrombopagromiplostimadisinsight
https://ce.massmed.nejm.org/nejm-weekly-cme/content/romiplostim-versus-placebo-chemotherapy-induced-thrombocytopenia
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia | MMS/NEJM Continuing...
for chemotherapyromiplostimversusplaceboinduced
https://adisinsight.springer.com/trials/700392336?error=cookies_not_supported&code=0c949547-9792-414b-96b3-a70a310d62ba
Romiplostim N01 in the Treatment of Refractory Chemoradiotherapy-induced Aplastic Anemia: a...
This study aimed to explore the efficacy and safety of romiplostim N01 in the treatment of relapsed/refractory chemoradiotherapy-induced aplastic anemia
in the
https://scholars.uky.edu/en/publications/rapid-response-to-mycophenolate-mofetil-in-combination-with-romip/
Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe...
https://portal.fis.tum.de/de/publications/prospective-validation-of-a-biomarker-driven-response-prediction-/fingerprints/
Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk...
https://pubmed.ncbi.nlm.nih.gov/27103127/
Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind,...
in childrenimmune thrombocytopenia